Topic
Psychedelics
90 published works
Health Law Prof Blog
Patents on Psychedelics: The Next Legal Battlefront of Drug Development
Mason Marks (Harvard Law School), I. Glenn Cohen (Harvard Law School), Patents on Psychedelics: The Next Legal Battlefront of Drug Development, 135 Harv. L. Rev. F. (forthcoming 2022):In the past…
Canna Law Blog
Dispatches from Wonderland Miami
Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). We were there, meeting industry insiders and clients, and keeping on the cutting edge of the psychedelics…
Canna Law Blog
Trademarking Psychedelics
Can companies in the psychedelic space register their trademarks, for psychedelics themselves? This is a question that often comes up, given U.S. trademark law’s requirement that marks be lawfully used…
Canna Law Blog
Is Psilocybin Really a Miracle Drug? Compass Pathways Releases Phase 2B Trial Results
Something strange happened yesterday. Psychedelics unicorn Compass Pathways released data for the largest clinical trial ever conducted of a psilocybin drug. Not only did the drug seem to work, but…
Marijuana Law, Policy & Reform
"A First Amendment Right to Burning Bush: Empowering the Free Exercise Clause to Protect Religious use of Psychedelic Drugs"
The title of this post is the title of this new paper recently posted to SSRN and authored by Michael McDonald, a recent graduate of The Ohio State University Moritz…
Canna Law Blog
Psychedelics, Cannabis and the Stock Exchanges
Last week, I came across an article surveying the 50 (!) psychedelics companies that are now publicly traded on U.S. exchanges— a handful of which we are proud to call…
Canna Law Blog
BREAKING: City of Seattle Decriminalizes Psychedelics
In a continuing trend across the country whereby cities are taking steps to decriminalize the possession of certain amounts of all kinds of psychedelics, Seattle joined the herd this week…
Canadian Lawyer Mag
Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S.
Ketamine infusions have become a popular treatment option for chronic diseases and pain disorders
Canna Law Blog
The Psychedelic Landscape: Pharma, Tech, Decrim, Other
We’ve been writing about psychedelics on this blog now for three years. I believe the first article I wrote covered Food and Drug Administration (FDA) approval of Compass Pathway’s drug…
Canna Law Blog
Harvard Law Announces Psychedelics Law Research Initiative, Led by Harris Bricken Attorney Mason Marks
Yesterday, on June 30, the Petrie-Flom Center at Harvard Law School announced the launch of a three-year research initiative, the Project on Psychedelics Law and Regulation (POPLAR). The initiative will…